UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016330
Receipt number R000018950
Scientific Title Analysis of novel treatment using Nek2 siRNA for non curative pancreas cancer.
Date of disclosure of the study information 2015/01/25
Last modified on 2021/04/17 09:18:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of novel treatment using Nek2 siRNA for non curative pancreas cancer.

Acronym

Nek2 siRNA for non curative pancreas cancer

Scientific Title

Analysis of novel treatment using Nek2 siRNA for non curative pancreas cancer.

Scientific Title:Acronym

Nek2 siRNA for non curative pancreas cancer

Region

Japan


Condition

Condition

non curative pancreas cancer.

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Safety of Nek2 SiRNA injection into the pancreatic cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

safety: AE within 28days

Key secondary outcomes

Efficacy


Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Gene

Interventions/Control_1

Injection Nek2 SiRNA into the panceatic cancer

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1.pancreas cancer
2.20y-85y
3.no treatment
4.ECOG PS 0-2
6.Labo data is normal
7.Prognosis is more than 3month.
8.IC

Key exclusion criteria

1.Immunodeficiency
2.Severe Infection
3.Severe complication
4.Pregnant
5.Drug allergy
6.Chronic disease
7.HIV, HBV, HCV
8.others

Target sample size

18


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo Hara

Organization

Aichi Cancer Center Hospital

Division name

Gastroenterology

Zip code


Address

1-1 kanokoden Tikusa-ku Nagoya

TEL

052-762-6111

Email

khara@aichi-cc.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuo Hara

Organization

Aichi Cancer Center Hospital

Division name

Gastroenterology

Zip code


Address

1-1 kanokoden Tikusa-ku Nagoya

TEL

052-762-6111

Homepage URL


Email

khara@aichi-cc.jp


Sponsor or person

Institute

Aichi Cancer Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Nagoya university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 07 Month 31 Day

Date of IRB

2014 Year 07 Month 01 Day

Anticipated trial start date

2014 Year 08 Month 01 Day

Last follow-up date

2021 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 25 Day

Last modified on

2021 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018950


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name